Lijun Zhao

Engineered T Cell Therapy for Cancer in the Clinic

Yu Cao, Lijun Zhao, 2019, Front. Immunol..

A tumor-targeted immune checkpoint blocker

P. Schultz, Rongsheng E. Wang, Shuhong Li, 2019, Proceedings of the National Academy of Sciences.

Synthesis of precision antibody conjugates using proximity-induced chemistry

Zeru Tian, Yu J Cao, A. Loredo, 2021, Theranostics.

Switchable CAR-T Cells Outperformed Traditional Antibody-Redirected Therapeutics Targeting Breast Cancers.

Stephanie A. Kazane, Zhidong Wang, Yu J Cao, 2021, ACS synthetic biology.

A Novel Her2/VEGFR2/CD3 trispecific antibody with an optimal structural design showed improved T-cell-redirecting antitumor efficacy

Bo Zhang, Dong Liu, Shuhong Li, 2022, Theranostics.

A novel CD19/CD22/CD3 trispecific antibody enhances therapeutic efficacy and overcomes immune escape against B-ALL.

Shuhong Li, F. Wen, Yu J Cao, 2022, Blood.